Judith Dunn
Director/Board Member en ELIEM THERAPEUTICS, INC. .
Fortuna: - $ al 31/03/2024
Perfil
Judith A.
Dunn is an Independent Non-Executive Director at Evolution Research Group LLC since 2018.
She is also an Independent Director at Eliem Therapeutics, Inc. since 2021.
Previously, she served as the Chairman at New York Biotechnology Association, Inc. from 2016 to 2018.
She was the Executive Medical Director at Sumitomo Pharma America, Inc. from 2005 to 2010.
Additionally, she held the position of Independent Director at Seelos Therapeutics, Inc. from 2020 to 2021.
She briefly served as the Chief Medical Officer at Fulcrum Therapeutics, Inc. in 2022.
Dr. Dunn completed her undergraduate degree at Rochester Christian University and obtained her doctorate degree from Wesleyan University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ELIEM THERAPEUTICS, INC.
-.--% | 18/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Judith Dunn
| Empresas | Cargo | Inicio |
|---|---|---|
| ELIEM THERAPEUTICS, INC. | Director/Board Member | 01/02/2021 |
Evolution Research Group LLC
 Evolution Research Group LLC Miscellaneous Commercial ServicesCommercial Services Evolution Research Group LLC provides in-patient and out-patient clinical trial services to pharmaceutical companies. It specializes in psychiatric and neurological disorders, sleep disorders, addictions, acute and chronic pain, renal insufficiency and hepatic impairment, and normal healthy volunteers. The company was founded in 2014 and is headquartered in New Providence, NJ. | Director/Board Member | 01/08/2018 |
Antiguos cargos conocidos de Judith Dunn.
| Empresas | Cargo | Fin |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 14/10/2022 |
| SEELOS THERAPEUTICS, INC. | Director/Board Member | 01/09/2021 |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Chairman | 01/06/2018 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01/01/2010 |
Formación de Judith Dunn.
| Rochester Christian University | Undergraduate Degree |
| Wesleyan University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| SEELOS THERAPEUTICS, INC. | Health Technology |
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Commercial Services |
Evolution Research Group LLC
Evolution Research Group LLC Miscellaneous Commercial ServicesCommercial Services Evolution Research Group LLC provides in-patient and out-patient clinical trial services to pharmaceutical companies. It specializes in psychiatric and neurological disorders, sleep disorders, addictions, acute and chronic pain, renal insufficiency and hepatic impairment, and normal healthy volunteers. The company was founded in 2014 and is headquartered in New Providence, NJ. | Commercial Services |
- Bolsa de valores
- Insiders
- Judith Dunn
